CClinicalTrials.gg
RecruitingNCT07220798iCare4Me HCUpdated Aug 12, 2026

Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment

An interventional study of ViCCY in Heart Failure, Cognitive Impairment and Caregiver Burden, sponsored by Visiting Nurse Service of New York. Recruiting at 1 site in United States. Open to participants aged 18 Years to 101 Years. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Visiting Nurse Service of New York · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started May 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
316
Allocation
Randomized
Ages
18 Years to 101 Years
Sex
All
01

Study summary

This RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator group, stratifying randomization by caregiver sex (male/female), relationship (spouse/partner or child), and race (white/other)- factors known to influence caregiving burden, perceived stress, and receptivity to the intervention. We will encourage caregivers to use their own devices but provide tablet devices with wireless network access if needed. The intervention group will receive 10 sessions of ViCCY over 6 months.

Read the detailed description

Purpose and Specific Aims

Cognitive Impairment (CI) has been reported to be as high as 78% in older adults with Heart Failure (HF). CI markedly increases the risk of adverse HF outcomes such as hospitalization and death, and patients with CI and HF are rarely able to manage without a caregiver. The high level of caregiving demands lead to an increase in stress and strained relationships with caregiving recipients, which can lead to poor coping and decreased mental health among caregivers. This study aims to test a self-care intervention (Virtual Caregiver Coach for You -ViCCY) targeting caregivers to support mental health and explore whether changes in caregiver mental health impacts patient outcomes. We will examine relationship strain as the primary mechanism for improvements in outcomes in patients and caregivers.

Aim 1: Test the efficacy of ViCCY vs. UC in improving outcomes of caregivers of home health care (HHC) patients with HF/CI.

Aim 2: Explore the effect of ViCCY on outcomes in HHC patients with HF/CI. At 6-months we will report differences in mental health measured with the SF-36 and its contributors of depression, anxiety, and somatic HF symptoms between patients whose caregivers are randomized to ViCCY compared to UC.

Aim 3: Describe the mechanisms by which outcomes are achieved.

Overview of Study Design and Methods

This RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator group, stratifying randomization by caregiver sex (male/female), relationship (spouse/partner or child), and race (white/other)- factors known to influence caregiving burden, perceived stress, and receptivity to the intervention. We will encourage caregivers to use their own devices but provide tablet devices with wireless network access if needed. The intervention group will receive 10 sessions of ViCCY over 6 months.

Participant Recruitment and Data Collection

Participants will be (256) caregivers of community dwelling older adults with HF/CI and 60 dyads (caregivers and patients) with HF and mild to moderate CI.

Data Sources and Analysis

We will use an intent-to-treat approach with the primary outcomes assessed at baseline, 3- and 6-months, and 12-months. Efficacy will be analyzed at 6-months. We will summarize participant characteristics using descriptive statistics. Shapiro-Wilk and Levin's tests will be used to assess distributional assumptions of normality. Mixed effects regression models will be used to assess intervention efficacy. Outcomes will be assessed using pre-post self-reported survey data.

02

Conditions studied

  • Heart Failure
  • Cognitive Impairment
  • Caregiver Burden

Keywords

  • heart failure
  • cognitive impairment
  • caregiver burden
  • caregiver stress
  • self-care
  • dyads
03

In context

Heart Failure

5,697 studies on the registry are indexed under Heart Failure; 1,219 are open to participants now.

This study's planned enrollment of 316 is above the median of 72 across 3,733 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Visiting Nurse Service of New York is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 101 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient Inclusion Criteria

    1. Older adults (=>50 years of age)
    2. Enrolled in Home Health Care
    3. Documented to have HF
    4. Mild to moderate CI on the BIMS or OASIS items
    5. Able to provide informed consent
    6. Able to provide self-report data
  • Caregiver Inclusion Criteria

    1. Adults (=>18 years of age)
    2. Spouse/partner/child or other informal caregiver living with or in close proximity to the patient
    3. Caregiver of a home care patient who is currently receiving or recently received services and who has mild to severe cognitive impairment
    4. Reporting poor self-care on screening (Health Self-Care Neglect scale score =>2)
    5. Reporting poor mental health on screening (screened with the PROMIS Global Mental Health 4a score \<12)
    6. Caregiving or supporting the patient at least 8 hours/week
    7. Able to complete the protocol, e.g., adequate vision and hearing, English speaking.
    8. Able to provide informed consent
    9. Able to use technology

Exclusion criteria

Exclusion Criteria:

  • Patient Exclusion Criteria

    1. Dementia (ICD-10 code for dementia)
    2. Enrolled in hospice
    3. Non-English speaking
  • Caregiver Exclusion Criteria 1. Non-English speaking
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
316 participants (estimated)

Study arms

  • Experimental
    ViCCY Intervention

    The intervention group will receive 10 sessions of ViCCY over 6-months.

    Behavioral: ViCCY

  • No intervention
    Usual Care

    Usual Home Health Care.

Interventions

  • BehavioralViCCY

    The intervention group will receive 10 Health Coach sessions of ViCCY over 6-months.

06

What researchers measure

Primary outcomes

  1. Short Form Health Survey (SF-36) (Both)

    Mental health is a state of mental well-being that enables people to cope with the stresses of life, realize their abilities, learn well and work well. The SF-36 provides standardized scores and national norms for comparison. The SF-36 is valid in many populations and caregivers. It is one of the common data elements.

    Time frame: Baseline, 3- and 6- and 12-months

Secondary outcomes

  1. Self-Care of Informal Caregiver Inventory (Caregiver)

    Behaviors performed to maintain health

    Time frame: Baseline, 3- and 6- and 12-months

  2. Perceived Stress Scale short form (Caregiver)

    Demands exceed ability to cope

    Time frame: Baseline, 3- and 6- and 12-months

  3. Brief-COPE (Caregiver)

    Ability to respond to stressors with appropriate adaptive coping resources.

    Time frame: Baseline, 3- and 6- and 12-months

  4. Dyadic Relationship Scale (Both)

    Measure of strain in the dyadic relationship

    Time frame: Baseline, 3- and 6- and 12-months

  5. HF Caregiver Questionnaire (Patient)

    load experienced when caring for a loved one

    Time frame: Baseline, 3- and 6- and 12-months

  6. Patient Health Questionnaire (PHQ-9) (Patient)

    Measures signs and symptoms of depression.

    Time frame: Baseline and 6-months

  7. Generalized Anxiety Disorder (GAD-7) (Patient)

    Measures signs and symptoms of Anxiety.

    Time frame: Baseline and 6-months

  8. HF Somatic Perception Scale (Patient)

    Measures symptoms of Heart Failure.

    Time frame: Baseline and 6-months

  9. Charlson Comorbidity Index (Patient)

    Captures patient Medications and Chronic Conditions.

    Time frame: Baseline and 6-months.

07

Study locations

1 of 1 sites recruiting
  • VNS Health
    New York, New York 10017, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07220798
Lead sponsor
Visiting Nurse Service of New York
Collaborators
University of Pennsylvania
Responsible party
Sponsor
First posted
Oct 24, 2025
Start date
May 28, 2026
Primary completion
Apr 28, 2030 (estimated)
Completion
Apr 28, 2030 (estimated)
Last update
Aug 12, 2026

Study contacts

Barbara Riegel, PhD, RN
Contact
briegel@nursing.upenn.edu
215.898.9927
Nicole Onorato, MPH
Contact
Nicole.Onorato@vnshealth.org
212-609-5770
Barbara Riegel, PhD, RN
principal investigator · VNS Health (formerly Visiting Nurse Service of New York)

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion